NeuroMetrix, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
NURO Nasdaq 3840 www.neurometrix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NeuroMetrix, Inc.

Here’s Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10 - Jan 6th, 2025 2:06 pm
NeuroMetrix to be Acquired by electroCore - Dec 17th, 2024 9:05 pm
NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth - Nov 6th, 2024 6:36 pm
NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023) - Nov 6th, 2024 10:11 am
NeuroMetrix Reports Q3 2024 Business Highlights - Nov 5th, 2024 12:00 pm
NeuroMetrix Reiterates its Review of Strategic Alternatives - Aug 13th, 2024 6:47 pm
NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023) - Aug 8th, 2024 12:43 pm
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options - Aug 6th, 2024 11:00 am
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - Jul 31st, 2024 6:03 pm
NeuroMetrix Reports Q1 2024 Business Highlights - May 15th, 2024 8:00 pm